Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
The immune response in the CNS in Theiler's virus induced demyelinating disease switches from an early adaptive response to a chronic innate-like response.
Bone health in chronic neurological diseases: a focus on multiple sclerosis and parkinsonian syndromes.
Baseline MxA mRNA Expression Predicts Interferon Beta Response in Multiple Sclerosis Patients.
Autophagy Is Required for Neutrophil-Mediated Inflammation.
Expression, Regulation and Function of MicroRNAs in Multiple Sclerosis.
Astroglial PGC-1alpha increases mitochondrial antioxidant capacity and suppresses inflammation: implications for multiple sclerosis.
Remote control-triggering of brain autoimmune disease in the gut.
DTI detects water diffusion abnormalities in the thalamus that correlate with an extremity pain episode in a patient with multiple sclerosis.
Switching therapies in MS: what are the options?
Regulatory T and B lymphocytes in a spontaneous autoimmune polyneuropathy.
Biological markers in cerebrospinal fluid for axonal impairment in multiple sclerosis: acetylcholinesterase activity cannot be considered a useful biomarker.
Longitudinally Extensive Varicella-Zoster Virus Myelitis in a Multiple Sclerosis Patient.
Acute transverse myelitis in childhood: A single centre experience from North India.
The reliability, precision and clinically meaningful change of walking assessments in multiple sclerosis.
Transverse myelitis due to Staphylococcus aureus may occur without contiguous spread.
Interaction between the protective effects of cannabidiol and palmitoylethanolamide in experimental model of multiple sclerosis in C57BL/6 mice.
Understanding disease processes in multiple sclerosis through magnetic resonance imaging studies in animal models.
Optimal design of clinical trials with biologics using dose-time-response models.
Varicella-zoster virus encephalomyelitis with a prominent demyelinating component.
Diagnostic tools for evaluating the impact of Focal Axonal Swellings arising in neurodegenerative diseases and/or traumatic brain injury.
Brain glycolipids suppress T helper cells and inhibit autoimmune demyelination.
Validation of the automated method VIENA: An accurate, precise, and robust measure of ventricular enlargement.
Multiple sclerosis in the Arabian Gulf countries: a consensus statement.
Microglia in central nervous system repair after injury.
The benefits and risks of alemtuzumab in multiple sclerosis.
Pages
« first
‹ previous
…
452
453
454
455
456
457
458
459
460
…
next ›
last »